Status:
TERMINATED
Collection of Biological Samples With Clinical Characterization of Covid-19 Patients
Lead Sponsor:
Centre Hospitalier Intercommunal Creteil
Conditions:
Covid-19
Eligibility:
All Genders
Phase:
NA
Brief Summary
Biological collection (blood sample) associated with clinical data from Covid-19 patients
Detailed Description
SARS-Cov2 is an emerging respiratory virus in the coronavirus family, responsible of the pandemic since November 2019. France, which has more than 17,000 deaths from the virus, is one of the main outb...
Eligibility Criteria
Inclusion
- Diagnosis of COVID-19 confirmed on RT-PCR test or chest scanner
- Any age
- Membership in the general social security system
- Inform consent signed by the patient or by legal representatives for minors
Exclusion
- Refusal of the patient or one of the legal representatives
Key Trial Info
Start Date :
May 31 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2023
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04363385
Start Date
May 31 2020
End Date
May 31 2023
Last Update
April 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre hospitalier intercommunal de Créteil
Créteil, France, 94010